Cargando…

Longitudinal decreases in multiple cerebrospinal fluid biomarkers of neuronal injury in symptomatic late onset Alzheimer’s disease

INTRODUCTION: Individuals in early stages of Alzheimer’s disease are a targeted population for secondary prevention trials aimed at preserving normal cognition. Understanding within-person biomarkers) change over time is critical for trial enrollment and design. METHODS: Longitudinal cerebrospinal f...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sutphen, Courtney L., McCue, Lena, Herries, Elizabeth M., Xiong, Chengjie, Ladenson, Jack H., Holtzman, David M., Fagan, Anne M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	2018
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6110083/ https://www.ncbi.nlm.nih.gov/pubmed/29580670 http://dx.doi.org/10.1016/j.jalz.2018.01.012

Ejemplares similares

Cerebrospinal fluid VILIP-1 and YKL-40, candidate biomarkers to diagnose, predict and monitor Alzheimer’s disease in a memory clinic cohort
por: Kester, Maartje I., et al.
Publicado: (2015)

Quantitative Label-Free Proteomics for Discovery of Biomarkers in Cerebrospinal Fluid: Assessment of Technical and Inter-Individual Variation
por: Perrin, Richard J., et al.
Publicado: (2013)

Diagnostic Cerebrospinal Fluid Biomarker in Early and Late Onset Multiple Sclerosis
por: Konen, Franz Felix, et al.
Publicado: (2022)

Chitinase-3-like 1 protein (CHI3L1) locus influences cerebrospinal fluid levels of YKL-40
por: Deming, Yuetiva, et al.
Publicado: (2016)

Identification and Validation of Novel Cerebrospinal Fluid Biomarkers for Staging Early Alzheimer's Disease
por: Perrin, Richard J., et al.
Publicado: (2011)

Late-onset spinal subdural hematoma following cerebrospinal fluid drainage tube removal
por: Hattori, Masashi, et al.
Publicado: (2022)

Apolipoprotein E levels in cerebrospinal fluid and the effects of ABCA1 polymorphisms
por: Wahrle, Suzanne E, et al.
Publicado: (2007)

Dural diverticulum with a symptomatic cerebrospinal fluid leak
por: Armstrong, Nicholas, et al.
Publicado: (2015)

Symptomatic late-onset hypogonadism but normal total testosterone: the importance of testosterone annual decrease velocity
por: La Vignera, Sandro, et al.
Publicado: (2020)

Cerebrospinal fluid tau and ptau(181) increase with cortical amyloid deposition in cognitively normal individuals: Implications for future clinical trials of Alzheimer's disease
por: Fagan, Anne M, et al.
Publicado: (2009)

Multiple γ-secretase product peptides are coordinately increased in concentration in the cerebrospinal fluid of a subpopulation of sporadic Alzheimer’s disease subjects
por: Hata, Saori, et al.
Publicado: (2012)

Fine Mapping of Genetic Variants in BIN1, CLU, CR1 and PICALM for Association with Cerebrospinal Fluid Biomarkers for Alzheimer's Disease
por: Kauwe, John S. K., et al.
Publicado: (2011)

Late-onset behavioral variant of frontotemporal lobar degeneration versus Alzheimer's disease: Interest of cerebrospinal fluid biomarker ratios
por: Marelli, Cecilia, et al.
Publicado: (2015)

Integrated proteomics reveals brain-based cerebrospinal fluid biomarkers in asymptomatic and symptomatic Alzheimer’s disease
por: Higginbotham, Lenora, et al.
Publicado: (2020)

Quantification of white matter cellularity and damage in preclinical and early symptomatic Alzheimer's disease
por: Wang, Qing, et al.
Publicado: (2019)

SNPs Associated with Cerebrospinal Fluid Phospho-Tau Levels Influence Rate of Decline in Alzheimer's Disease
por: Cruchaga, Carlos, et al.
Publicado: (2010)

Cerebrospinal Fluid Pressure Decreases with Older Age
por: Fleischman, David, et al.
Publicado: (2012)

Cerebrospinal fluid markers for synaptic function and Alzheimer type changes in late life depression
por: Siafarikas, Nikias, et al.
Publicado: (2021)

Association of Longitudinal Changes in Cerebrospinal Fluid Total Tau and Phosphorylated Tau 181 and Brain Atrophy With Disease Progression in Patients With Alzheimer Disease
por: Llibre-Guerra, Jorge J., et al.
Publicado: (2019)

Delayed presentation of late-onset cerebrospinal fluid rhinorrhoea following dopamine agonist therapy for giant prolactinoma
por: Prague, J K, et al.
Publicado: (2014)

Before it is too late: professional responsibilities in late-onset Alzheimer’s research and pre-symptomatic prediction
por: Schicktanz, Silke, et al.
Publicado: (2014)

Cerebrospinal fluid amyloid-β 2-42 is decreased in Alzheimer’s, but not in frontotemporal dementia
por: Bibl, Mirko, et al.
Publicado: (2012)

Cerebrospinal Fluid Aβ43 Is Reduced in Early-Onset Compared to Late-Onset Alzheimer’s Disease, But Has Similar Diagnostic Accuracy to Aβ42
por: Lauridsen, Camilla, et al.
Publicado: (2017)

Elevation of Cerebrospinal Fluid Light and Heavy Neurofilament Levels in Symptomatic Neurosyphilis
por: Xu, Dong-mei, et al.
Publicado: (2020)

Analysis of the Cerebrospinal Fluid Proteome in Alzheimer's Disease
por: Khoonsari, Payam Emami, et al.
Publicado: (2016)

Identifying amyloid pathology–related cerebrospinal fluid biomarkers for Alzheimer's disease in a multicohort study
por: Leung, Yuk Yee, et al.
Publicado: (2015)

Cerebrospinal fluid biomarkers of infantile congenital hydrocephalus
por: Limbrick, David D., et al.
Publicado: (2017)

Exploration of the Core Pathways and Potential Targets of Luteolin Treatment on Late-Onset Depression Based on Cerebrospinal Fluid Proteomics
por: Liu, Kaige, et al.
Publicado: (2023)

Disease Biomarkers in Cerebrospinal Fluid of Patients with First-Onset Psychosis
por: Huang, Jeffrey T.-J, et al.
Publicado: (2006)

A map of neurofilament light chain species in brain and cerebrospinal fluid and alterations in Alzheimer’s disease
por: Budelier, Melissa M., et al.
Publicado: (2022)

Cerebrospinal fluid proteomics define the natural history of autosomal dominant Alzheimer’s disease
por: Johnson, Erik C. B., et al.
Publicado: (2023)

More advanced Alzheimer's disease may be associated with a decrease in cerebrospinal fluid pressure
por: Wostyn, Peter, et al.
Publicado: (2009)

Decreased CX3CL1 Levels in the Cerebrospinal Fluid of Patients With Alzheimer’s Disease
por: Perea, Juan R., et al.
Publicado: (2018)

MicroRNA Expression Levels Are Altered in the Cerebrospinal Fluid of Patients with Young-Onset Alzheimer’s Disease
por: McKeever, Paul M., et al.
Publicado: (2018)

Cerebrospinal fluid biomarkers of Alzheimer's disease in a cohort of adults with Down syndrome
por: Henson, Rachel L., et al.
Publicado: (2020)

Symptomatic Cryptococcal Meningitis with Negative Serum and Cerebrospinal Fluid Cryptococcal Antigen Tests
por: Nanfuka, Vivien, et al.
Publicado: (2021)

Author Correction: Cerebrospinal fluid markers for synaptic function and Alzheimer type changes in late life depression
por: Siafarikas, Nikias, et al.
Publicado: (2022)

Late-Onset Intractable Cerebrospinal Fluid Leakage After Stereotactic Radiotherapy After Resection of Giant Nonfunctioning Pituitary Adenoma
por: Nihonmatsu, Ayano, et al.
Publicado: (2019)

Proenkephalin Decreases in Cerebrospinal Fluid with Symptom Progression of Huntington's Disease
por: Niemela, Valter, et al.
Publicado: (2020)

The relevance of cerebrospinal fluid α-synuclein levels to sporadic and familial Alzheimer’s disease
por: Twohig, Daniel, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_cog7t3l56itciu57re52ndbfki